Tomoko Ichiki

1.7k total citations
69 papers, 1.2k citations indexed

About

Tomoko Ichiki is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Tomoko Ichiki has authored 69 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Cardiology and Cardiovascular Medicine, 16 papers in Molecular Biology and 14 papers in Oncology. Recurrent topics in Tomoko Ichiki's work include Heart Failure Treatment and Management (32 papers), Peptidase Inhibition and Analysis (10 papers) and Cardiac Fibrosis and Remodeling (10 papers). Tomoko Ichiki is often cited by papers focused on Heart Failure Treatment and Management (32 papers), Peptidase Inhibition and Analysis (10 papers) and Cardiac Fibrosis and Remodeling (10 papers). Tomoko Ichiki collaborates with scholars based in United States, Japan and India. Tomoko Ichiki's co-authors include John C. Burnett, S. Jeson Sangaralingham, Brenda K. Huntley, Paul M. McKie, Horng H. Chen, Fernando L. Martín, Michihisa Jougasaki, Gerald E. Harders, Manabu Setoguchi and Sharon M. Sandberg and has published in prestigious journals such as Circulation, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

Tomoko Ichiki

67 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoko Ichiki United States 22 779 261 175 144 130 69 1.2k
Akihiro Hirashiki Japan 19 594 0.8× 229 0.9× 187 1.1× 197 1.4× 111 0.9× 75 1.1k
S. Jeson Sangaralingham United States 25 1.1k 1.4× 290 1.1× 279 1.6× 155 1.1× 72 0.6× 66 1.5k
Alessandro Fucili Italy 16 441 0.6× 365 1.4× 136 0.8× 141 1.0× 113 0.9× 29 1.1k
Inge Goovaerts Belgium 13 405 0.5× 272 1.0× 83 0.5× 105 0.7× 145 1.1× 25 916
Tsuneo Ogawa Canada 14 674 0.9× 278 1.1× 150 0.9× 183 1.3× 53 0.4× 26 1.2k
Ralf Kaiser Germany 15 887 1.1× 303 1.2× 295 1.7× 235 1.6× 81 0.6× 34 1.6k
Jan R. Ortlepp Germany 24 620 0.8× 178 0.7× 176 1.0× 324 2.3× 93 0.7× 55 1.4k
Nandini Nair United States 16 429 0.6× 244 0.9× 95 0.5× 312 2.2× 67 0.5× 72 988
Navin Suthahar Netherlands 16 674 0.9× 265 1.0× 78 0.4× 127 0.9× 105 0.8× 44 1.2k
José R. Matos‐Souza Brazil 19 738 0.9× 286 1.1× 174 1.0× 221 1.5× 96 0.7× 74 1.5k

Countries citing papers authored by Tomoko Ichiki

Since Specialization
Citations

This map shows the geographic impact of Tomoko Ichiki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Ichiki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Ichiki more than expected).

Fields of papers citing papers by Tomoko Ichiki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Ichiki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Ichiki. The network helps show where Tomoko Ichiki may publish in the future.

Co-authorship network of co-authors of Tomoko Ichiki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Ichiki. A scholar is included among the top collaborators of Tomoko Ichiki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Ichiki. Tomoko Ichiki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yokoyama, Yoshihiro, Tomoko Ichiki, Tsukasa Yamakawa, et al.. (2024). Gut microbiota and metabolites in patients with COVID-19 are altered by the type of SARS-CoV-2 variant. Frontiers in Microbiology. 15. 1358530–1358530. 6 indexed citations
2.
Yokoyama, Yoshihiro, Tomoko Ichiki, Tsukasa Yamakawa, et al.. (2022). Impaired tryptophan metabolism in the gastrointestinal tract of patients with critical coronavirus disease 2019. Frontiers in Medicine. 9. 941422–941422. 9 indexed citations
3.
Ma, Xiao, Yang Chen, Christopher G. Scott, et al.. (2021). Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure. JACC Heart Failure. 9(9). 613–623. 8 indexed citations
4.
Ichiki, Tomoko, et al.. (2020). CENDERITIDE: A NOVEL THERAPEUTIC TO INCREASE ENDOGENOUS CARDIAC NATRIURETIC PEPTIDES IN HEART FAILURE. Journal of the American College of Cardiology. 75(11). 788–788. 2 indexed citations
5.
Chen, Yang, Gail J. Harty, Ye Zheng, et al.. (2019). CRRL269 AS AN INNOVATIVE PARTICULATE GUANYLYL CYCLASE RECEPTOR (GC-A) PEPTIDE ACTIVATOR FOR ACUTE KIDNEY INJURY TREATMENT. Journal of the American College of Cardiology. 73(9). 3065–3065. 1 indexed citations
6.
Ichiki, Tomoko, Kazunari Sugita, Masutaka Furue, & Osamu Yamamoto. (2019). An Intimate Relationship Between Intralesional Depigmentation and Peripheral Nervous System in Lichen Simplex Chronicus. Acta Dermato Venereologica. 100(1). 0–0. 1 indexed citations
7.
Yang, Chen, Ye Zheng, Seethalakshmi Iyer, et al.. (2019). C53: A novel particulate guanylyl cyclase B receptor activator that has sustained activity in vivo with anti-fibrotic actions in human cardiac and renal fibroblasts. Journal of Molecular and Cellular Cardiology. 130. 140–150. 22 indexed citations
8.
Ichiki, Tomoko, Nina Dzhoyashvili, & John C. Burnett. (2018). Natriuretic peptide based therapeutics for heart failure: Cenderitide: A novel first-in-class designer natriuretic peptide. International Journal of Cardiology. 281. 166–171. 35 indexed citations
9.
Meems, Laura M.G., Brenda K. Huntley, Gail J. Harty, et al.. (2017). NPA7, A FIRST IN CLASS DUAL RECEPTOR ACTIVATOR WITH CARDIO-RENOPROTECTIVE PROPERTIES IN VIVO. Journal of the American College of Cardiology. 69(11). 2554–2554. 1 indexed citations
10.
Sangaralingham, S. Jeson, Brenda K. Huntley, Tomoko Ichiki, & John C. Burnett. (2016). Abstract 12893: Design and cGMP-Generating Actions of a Novel Selective and Non-Selective Particulate Guanylyl Cyclase B Activator Targeting Cardiorenal Fibrotic Remodeling. Circulation. 134(suppl_1). 1 indexed citations
11.
Lee, Candace Y.W., Brenda K. Huntley, Daniel McCormick, et al.. (2015). Cenderitide: structural requirements for the creation of a novel dual particulate guanylyl cyclase receptor agonist with renal-enhancingin vivoandex vivoactions. European Heart Journal - Cardiovascular Pharmacotherapy. 2(2). 98–105. 21 indexed citations
12.
Shimokawahara, Hiroto, Michihisa Jougasaki, Manabu Setoguchi, et al.. (2014). Relationship between vascular endothelial growth factor and left ventricular dimension in patients with acute myocardial infarction. Journal of Cardiology. 64(5). 360–365. 6 indexed citations
13.
Ichiki, Tomoko, Brenda K. Huntley, & J. C. Burnett. (2013). BNP Molecular Forms and Processing by the Cardiac Serine Protease Corin. Advances in clinical chemistry. 61. 1–31. 45 indexed citations
14.
Jougasaki, Michihisa, et al.. (2013). Cardiotrophin-1 Induces Matrix Metalloproteinase-1 in Human Aortic Endothelial Cells. PLoS ONE. 8(7). e68801–e68801. 10 indexed citations
15.
Martín, Fernando L., S. Jeson Sangaralingham, Brenda K. Huntley, et al.. (2012). CD-NP: A Novel Engineered Dual Guanylyl Cyclase Activator with Anti-Fibrotic Actions in the Heart. PLoS ONE. 7(12). e52422–e52422. 48 indexed citations
16.
McKie, Paul M., Alessandro Cataliotti, S. Jeson Sangaralingham, et al.. (2011). Predictive Utility of Atrial, N-Terminal Pro-Atrial, and N-Terminal Pro-B-Type Natriuretic Peptides for Mortality and Cardiovascular Events in the General Community: A 9-Year Follow-up Study. Mayo Clinic Proceedings. 86(12). 1154–1160. 49 indexed citations
17.
Sangaralingham, S. Jeson, Brenda K. Huntley, Fernando L. Martín, et al.. (2010). The Aging Heart, Myocardial Fibrosis, and its Relationship to Circulating C-Type Natriuretic Peptide. Hypertension. 57(2). 201–207. 94 indexed citations
18.
19.
Yoshinaga, Masao, Tomoko Ichiki, Yuji Tanaka, et al.. (2009). Prevalence of childhood obesity from 1978 to 2007 in Japan. Pediatrics International. 52(2). 213–217. 45 indexed citations
20.
Saihara, Keishi, Shuichi Hamasaki, Hideki Okui, et al.. (2006). Association of coronary shear stress with endothelial function and vascular remodeling in patients with normal or mildly diseased coronary arteries. Coronary Artery Disease. 17(5). 401–407. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akihiro Hirashiki Breakdown of academic impact, for papers by S. Jeson Sangaralingham Breakdown of academic impact, for papers by Alessandro Fucili Breakdown of academic impact, for papers by Inge Goovaerts Breakdown of academic impact, for papers by Tsuneo Ogawa Breakdown of academic impact, for papers by Ralf Kaiser Breakdown of academic impact, for papers by Jan R. Ortlepp Breakdown of academic impact, for papers by Nandini Nair Breakdown of academic impact, for papers by Navin Suthahar Breakdown of academic impact, for papers by José R. Matos‐Souza
Rankless by CCL
2026